BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16938311)

  • 1. Modeling the effects of vasculature evolution on early brain tumor growth.
    Gevertz JL; Torquato S
    J Theor Biol; 2006 Dec; 243(4):517-31. PubMed ID: 16938311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mathematical model of tumour angiogenesis, regulated by vascular endothelial growth factor and the angiopoietins.
    Plank MJ; Sleeman BD; Jones PF
    J Theor Biol; 2004 Aug; 229(4):435-54. PubMed ID: 15246783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomas.
    Bian XW; Jiang XF; Chen JH; Bai JS; Dai C; Wang QL; Lu JY; Zhao W; Xin R; Liu MY; Shi JQ; Wang JM
    Int Immunopharmacol; 2006 Jan; 6(1):90-9. PubMed ID: 16332517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
    Shibuya M
    FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells.
    Oka N; Soeda A; Inagaki A; Onodera M; Maruyama H; Hara A; Kunisada T; Mori H; Iwama T
    Biochem Biophys Res Commun; 2007 Aug; 360(3):553-9. PubMed ID: 17618600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour vasculature and angiogenic profile of paediatric pilocytic astrocytoma; is it much different from glioblastoma?
    Sie M; de Bont ES; Scherpen FJ; Hoving EW; den Dunnen WF
    Neuropathol Appl Neurobiol; 2010 Dec; 36(7):636-47. PubMed ID: 20704656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioblastoma angiogenesis: VEGF resistance solutions and new strategies based on molecular mechanisms of tumor vessel formation.
    Takano S
    Brain Tumor Pathol; 2012 Apr; 29(2):73-86. PubMed ID: 22218709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor angiogenesis].
    Bikfalvi A
    Bull Cancer; 2007; 94(7 Suppl):F193-8. PubMed ID: 17964996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Angiogenesis and anti-angiogenic strategies for glioblastoma].
    de Boüard S; Guillamo JS
    Bull Cancer; 2005 Apr; 92(4):360-72. PubMed ID: 15888393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
    Wada H; Nagano H; Yamamoto H; Arai I; Ota H; Nakamura M; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Doki Y; Dono K; Nakamori S; Sakon M; Monden M
    Oncol Rep; 2007 Oct; 18(4):801-9. PubMed ID: 17786339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models.
    Pisati F; Belicchi M; Acerbi F; Marchesi C; Giussani C; Gavina M; Javerzat S; Hagedorn M; Carrabba G; Lucini V; Gaini SM; Bresolin N; Bello L; Bikfalvi A; Torrente Y
    Cancer Res; 2007 Apr; 67(7):3054-63. PubMed ID: 17409412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of tumor growth and combination of anti-angiogenic and cytotoxic therapies.
    Kohandel M; Kardar M; Milosevic M; Sivaloganathan S
    Phys Med Biol; 2007 Jul; 52(13):3665-77. PubMed ID: 17664569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular changes in hepatocellular carcinoma.
    Yang ZF; Poon RT
    Anat Rec (Hoboken); 2008 Jun; 291(6):721-34. PubMed ID: 18484619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular morphology and angiogenesis in glial tumors.
    Plate KH; Mennel HD
    Exp Toxicol Pathol; 1995 May; 47(2-3):89-94. PubMed ID: 7580112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice.
    Brantley-Sieders DM; Fang WB; Hwang Y; Hicks D; Chen J
    Cancer Res; 2006 Nov; 66(21):10315-24. PubMed ID: 17079451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor (VEGF) signaling in tumor progression.
    Roskoski R
    Crit Rev Oncol Hematol; 2007 Jun; 62(3):179-213. PubMed ID: 17324579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting tumor angiogenesis.
    Gaur P; Bose D; Samuel S; Ellis LM
    Semin Oncol; 2009 Apr; 36(2 Suppl 1):S12-9. PubMed ID: 19393831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease of endogenous vascular endothelial growth factor may not affect glioma cell proliferation and invasion.
    Hong X; Jiang F; Kalkanis SN; Zhang ZG; Zhang X; Zheng X; Mikkelsen T; Jiang H; Chopp M
    J Exp Ther Oncol; 2007; 6(3):219-29. PubMed ID: 17552362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis.
    Kang KB; Wang TT; Woon CT; Cheah ES; Moore XL; Zhu C; Wong MC
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):888-96. PubMed ID: 17293239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-steroid regulation of vascular endothelial growth factor in breast cancer.
    Hyder SM
    Endocr Relat Cancer; 2006 Sep; 13(3):667-87. PubMed ID: 16954424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.